Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-17 Purchase | 2021-12-21 8:39 pm | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation of Responses 10% Owner | 400 | $6.5858 | $2,634 | 8,017,241 (Indirect) | View |
| 2021-12-14 Purchase | 2021-12-16 11:37 am | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation of Responses 10% Owner | 412 | $5.895 | $2,429 | 8,016,841 (Indirect) | View |
| 2021-12-03 Purchase | 2021-12-03 7:58 pm | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation of Responses 10% Owner | 4,500 | $5.93 | $26,685 | 8,016,429 (Indirect) | View |
| 2021-12-02 Purchase | 2021-12-03 11:16 am | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation Response 10% Owner | 13,836 | $5.3 | $73,331 | 8,011,929 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-13 Option Award | 2024-06-17 4:23 pm | N/A 2034-06-12 | Anebulo Pharmaceuticals Inc. | ANEB | Lin Kenneth Director | 44,149 | $0 | 44,149 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:23 pm | N/A 2034-06-12 | Anebulo Pharmaceuticals Inc. | ANEB | Calloway Nathaniel Director | 43,322 | $0 | 43,322 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:23 pm | N/A 2034-06-12 | Anebulo Pharmaceuticals Inc. | ANEB | Kupchyk Areta Director | 42,991 | $0 | 42,991 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:23 pm | N/A 2034-06-12 | Anebulo Pharmaceuticals Inc. | ANEB | Lawler Joseph F. Director | 48,285 | $0 | 48,285 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:23 pm | N/A 2034-06-12 | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. Director 10% Owner | 42,991 | $0 | 42,991 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:23 pm | N/A 2034-06-12 | Anebulo Pharmaceuticals Inc. | ANEB | SHAH BIMAL R. Director | 44,976 | $0 | 44,976 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:23 pm | N/A 2034-06-12 | Anebulo Pharmaceuticals Inc. | ANEB | Aryeh Jason Director | 44,149 | $0 | 44,149 (Direct) | View |
| 2024-02-29 Option Award(A) | 2024-03-08 08:07 am | N/A 2034-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer | 72,613 | $0 | 72,613 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-01 6:24 pm | N/A 2034-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer | 72,613 | $0 | 72,613 (Direct) | View |
| 2023-12-18 Gift | 2023-12-20 4:22 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW LP 22NW Fund LP Director 10% Owner | 300,000 | $0 | 10,020,818 (Indirect) | View |
| 2023-11-13 Option Award | 2023-12-20 4:22 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW LP 22NW Fund LP Director 10% Owner | 300,000 | $0 | 10,020,818 (Indirect) | View |
| 2023-10-06 Option Award | 2023-10-11 5:25 pm | N/A 2033-10-05 | Anebulo Pharmaceuticals Inc. | ANEB | Cunningham Richard Anthony Chief Executive Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2023-10-06 Option Award | 2023-10-10 9:49 pm | N/A 2033-10-05 | Anebulo Pharmaceuticals Inc. | ANEB | SHAH BIMAL R. Director | 26,097 | $0 | 26,097 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 9:19 pm | N/A 2032-12-08 | Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer | 35,017 | $0 | 35,017 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 9:18 pm | N/A 2032-12-08 | Anebulo Pharmaceuticals Inc. | ANEB | ALLEN SIMON Chief Executive Officer | 70,246 | $0 | 70,246 (Direct) | View |
| 2022-11-01 Option Award | 2022-11-02 4:31 pm | N/A 2027-10-31 | Anebulo Pharmaceuticals Inc. | ANEB | Calloway Nathaniel Director | 59,149 | $0 | 59,149 (Direct) | View |
| 2022-04-21 Option Award | 2022-10-04 4:13 pm | N/A 2027-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Lawler Joseph F. Director 10% Owner | 30,425 | $0 | 12,030,425 (Direct) | View |
| 2022-04-21 Option Award | 2022-10-04 4:11 pm | N/A 2027-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Lin Kenneth Director | 30,425 | $0 | 30,425 (Direct) | View |
| 2022-04-21 Option Award | 2022-10-03 7:56 pm | N/A 2027-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director | 30,425 | $0 | 30,425 (Direct) | View |
| 2022-04-21 Option Award | 2022-10-03 7:53 pm | N/A 2027-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Aryeh Jason Director | 30,425 | $0 | 30,425 (Direct) | View |
| 2022-04-21 Option Award | 2022-10-03 7:51 pm | N/A 2027-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Kupchyk Areta Director | 30,425 | $0 | 30,425 (Direct) | View |
| 2022-06-27 Option Award | 2022-10-03 7:48 pm | N/A 2027-07-31 | Anebulo Pharmaceuticals Inc. | ANEB | ALLEN SIMON Chief Executive Officer | 77,457 | $0 | 77,457 (Direct) | View |
| 2022-09-28 Option Award | 2022-09-30 9:36 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP Director 10% Owner | 1,703,577 | $2.81 | 11,454,820 (Indirect) | View |
| 2022-09-28 Option Award | 2022-09-30 9:36 pm | 2022-09-28 2027-09-28 | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP Director 10% Owner | 1,703,577 | $0.125 | 11,454,820 (Direct) | View |
| 2022-04-21 Option Award | 2022-09-30 9:36 pm | N/A 2027-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP Director 10% Owner | 30,425 | $0 | 11,454,820 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-07 4:10 pm | 2022-07-01 2027-06-30 | Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer | 350,169 | $0 | 350,169 (Direct) | View |
| 2022-02-07 Option Award | 2022-02-07 4:07 pm | 2022-04-01 2027-01-31 | Anebulo Pharmaceuticals Inc. | ANEB | ALLEN SIMON Chief Executive Officer | 625,000 | $0 | 625,000 (Direct) | View |
| 2021-05-06 Option Award(A) | 2021-05-17 9:47 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation of Responses 10% Owner | 714,250 | $7 | 7,998,093 (Indirect) | View |
| 2021-05-06 Option Award | 2021-05-07 7:23 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW LP See Explanation of Responses 10% Owner | 714,286 | $7 | 7,998,129 (Indirect) | View |
Ownership | 2021-05-06 8:47 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director | 0 | $0 | 82,290 (Direct) | View |
Ownership | 2021-05-06 8:45 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | Aryeh Jason Director | 0 | $0 | 82,290 (Direct) | View |